Clinical Trial Update: A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A safety and tolerability study of NC318 in advanced or metastatic solid tumors completed Phase 1/2 with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cholangiocarcinoma
• Colorectal Cancer
• Endometrial Cancer
• Head and Neck Squamous Cell Carcinoma
• Lung Cancer
• Melanoma
• Or Metastatic Solid Tumors
• Urothelial Carcinoma

Drugs mentioned

• NC318

Snippet

Sponsor: NextCure, Inc. | Conditions: Advanced or Metastatic Solid Tumors, Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-03-08